Cybin announces overnight marketed public offering of units

Toronto--(business wire)--cybin inc. (nyse american:cybn) (neo:cybn) (“cybin” or the “company”), a clinical-stage biopharmaceutical company committed to revolutionizing mental healthcare by developing new and innovative psychedelic-based treatment options, is pleased to announce that it has launched an overnight marketed public offering of units of the company (the “units”) at a price per unit and for aggregate gross proceeds to be determined in the context of the market (the “offering”). each.
CYBN Ratings Summary
CYBN Quant Ranking